Real-world practice patterns and impact of PD-L1 expression testing in patients with advanced non-small cell lung cancer.

被引：0
|
作者：
Leapman, Michael
Presley, Carolyn J.
Zhu, Weiwei
Soulos, Pamela R.
Adelson, Kerin B.
Boffa, Daniel J.
Gross, Cary Philip
机构：
[1] Yale Sch Med, New Haven, CT USA
[2] Ohio State Univ, Columbus, OH 43210 USA
[3] Yale Univ, New Haven, CT USA
[4] Yale Sch Med, Thorac Surg Sect, Dept Surg, New Haven, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9059
引用
收藏
页数：1
相关论文
共 50 条
  • [21] PD-L1 expression and its significance in Chinese patients with non-small cell lung cancer.
    Sharma, Susmita
    Ren, Xiubao
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [22] Real-world evidence and clinical observations of the treatment of advanced non-small cell lung cancer with PD-1/PD-L1 inhibitors
    Peng Song
    Jingcheng Zhang
    Congcong Shang
    Li Zhang
    Scientific Reports, 9
  • [23] Real-world evidenceand clinical observations of the treatment of advanced non-small cell lung cancer with PD-1/PD-L1 inhibitors
    Song, Peng
    Zhang, Jingcheng
    Shang, Congcong
    Zhang, Li
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [24] Real-world treatment patterns before and after receiving PD-L1 test results in patients (pts) with advanced non-small cell lung cancer (aNSCLC)
    Antonia, S. J.
    Wu, N.
    Ge, W.
    Pouliot, J-F.
    Dietz, H.
    Jalbert, J.
    Quek, R. G.
    Harnett, J.
    ANNALS OF ONCOLOGY, 2021, 32 : S1419 - S1420
  • [25] Real-world study of PD-L1 testing patterns and treatment distribution in patients with metastatic non-small-cell lung cancer in Israel
    Moser, Sarah Sharman
    Apter, Lior
    Arunachalam, Ashwini
    Burke, Thomas
    Shalev, Varda
    Chodick, Gabriel
    Siegelmann-Danieli, Nava
    IMMUNOTHERAPY, 2021, 13 (10) : 851 - 861
  • [26] Association of PD-L1 protein expression and TMB in non-small cell lung cancer.
    Chen, Yaru
    Zhou, Yanqing
    Xu, Yun
    Zhang, Xiaoni
    Xu, Mingyan
    Melancon, Charles E.
    Chen, Shifu
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [27] Real-World Efficacy of First-Line Pembrolizumab in Patients with Advanced PD-L1 High Non-Small Cell Lung Cancer in Argentina
    Kuzminin, A.
    Minatta, N.
    Bluthgen, M.
    Rizzo, M.
    Naveira, M.
    Wainsztein, V.
    Lupinacci, L.
    Rizzi, M.
    Faura, M.
    Perfetti, A.
    Recondo, G., Jr.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S589 - S590
  • [28] The Efficacy of PD-1/PD-L1 Inhibitors in Patients with Liver Metastasis of Non-Small Cell Lung Cancer: A Real-World Study
    Xie, Mingying
    Li, Na
    Xu, Xiaoling
    Xu, Yanjun
    Li, Hui
    Zhu, Liang
    Sheng, Jiamin
    Zhou, Zichao
    Fan, Yun
    CANCERS, 2022, 14 (17)
  • [29] Real-world utilization of PD-1/PD-L1 inhibitors with palliative radiotherapy in patients with metastatic non-small cell lung cancer
    Zhou, Zi-Chao
    Chen, Kai-Yan
    Li, Na
    Xie, Ming-Ying
    Sheng, Jia-Min
    Fan, Yun
    Huang, Zhi-Yu
    THORACIC CANCER, 2022, 13 (16) : 2291 - 2300
  • [30] PREDICTORS OF PD-L1 TESTING IN NON-SMALL CELL LUNG CANCER
    DiBonaventura, M.
    Meyers, A.
    Higginbottom, K.
    Morimoto, Y.
    Ilacqua, J.
    VALUE IN HEALTH, 2016, 19 (07) : A763 - A763
12345